iRhythm Technologies, Inc.

NasdaqGS:IRTC Rapporto sulle azioni

Cap. di mercato: US$2.2b

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

iRhythm Technologies Gestione

Gestione criteri di controllo 2/4

iRhythm Technologies' Il CEO è Quentin Blackford, nominato in Oct2021, e ha un mandato di 2.83 anni. la retribuzione annua totale è $ 16.60M, composta da 4.1% di stipendio e 95.9% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.23% delle azioni della società, per un valore di $ 4.73M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 2.3 anni e 7.1 anni.

Informazioni chiave

Quentin Blackford

Amministratore delegato

US$16.6m

Compenso totale

Percentuale dello stipendio del CEO4.1%
Mandato del CEO2.8yrs
Proprietà del CEO0.2%
Durata media del management2.3yrs
Durata media del Consiglio di amministrazione7.1yrs

Aggiornamenti recenti sulla gestione

Recent updates

Getting In Cheap On iRhythm Technologies, Inc. (NASDAQ:IRTC) Might Be Difficult

Jul 13
Getting In Cheap On iRhythm Technologies, Inc. (NASDAQ:IRTC) Might Be Difficult

iRhythm Technologies (NASDAQ:IRTC) Is Carrying A Fair Bit Of Debt

May 13
iRhythm Technologies (NASDAQ:IRTC) Is Carrying A Fair Bit Of Debt

iRhythm Technologies, Inc.'s (NASDAQ:IRTC) Business Is Trailing The Industry But Its Shares Aren't

Mar 25
iRhythm Technologies, Inc.'s (NASDAQ:IRTC) Business Is Trailing The Industry But Its Shares Aren't

Here's What Analysts Are Forecasting For iRhythm Technologies, Inc. (NASDAQ:IRTC) After Its Annual Results

Feb 25
Here's What Analysts Are Forecasting For iRhythm Technologies, Inc. (NASDAQ:IRTC) After Its Annual Results

iRhythm Technologies (NASDAQ:IRTC) Has Debt But No Earnings; Should You Worry?

Feb 02
iRhythm Technologies (NASDAQ:IRTC) Has Debt But No Earnings; Should You Worry?

iRhythm Technologies, Inc. (NASDAQ:IRTC) Shares Could Be 30% Below Their Intrinsic Value Estimate

Dec 20
iRhythm Technologies, Inc. (NASDAQ:IRTC) Shares Could Be 30% Below Their Intrinsic Value Estimate

iRhythm Technologies, Inc. (NASDAQ:IRTC) Stocks Shoot Up 25% But Its P/S Still Looks Reasonable

Dec 20
iRhythm Technologies, Inc. (NASDAQ:IRTC) Stocks Shoot Up 25% But Its P/S Still Looks Reasonable

Is Now An Opportune Moment To Examine iRhythm Technologies, Inc. (NASDAQ:IRTC)?

Dec 02
Is Now An Opportune Moment To Examine iRhythm Technologies, Inc. (NASDAQ:IRTC)?

Health Check: How Prudently Does iRhythm Technologies (NASDAQ:IRTC) Use Debt?

Sep 20
Health Check: How Prudently Does iRhythm Technologies (NASDAQ:IRTC) Use Debt?

iRhythm Technologies, Inc. (NASDAQ:IRTC) Shares Could Be 25% Below Their Intrinsic Value Estimate

Aug 30
iRhythm Technologies, Inc. (NASDAQ:IRTC) Shares Could Be 25% Below Their Intrinsic Value Estimate

When Should You Buy iRhythm Technologies, Inc. (NASDAQ:IRTC)?

Jul 04
When Should You Buy iRhythm Technologies, Inc. (NASDAQ:IRTC)?

Is iRhythm Technologies (NASDAQ:IRTC) Using Debt In A Risky Way?

Jun 16
Is iRhythm Technologies (NASDAQ:IRTC) Using Debt In A Risky Way?

Estimating The Intrinsic Value Of iRhythm Technologies, Inc. (NASDAQ:IRTC)

May 26
Estimating The Intrinsic Value Of iRhythm Technologies, Inc. (NASDAQ:IRTC)

iRhythm Technologies, Inc.'s (NASDAQ:IRTC) P/S Is On The Mark

May 08
iRhythm Technologies, Inc.'s (NASDAQ:IRTC) P/S Is On The Mark

What Does iRhythm Technologies, Inc.'s (NASDAQ:IRTC) Share Price Indicate?

Mar 27
What Does iRhythm Technologies, Inc.'s (NASDAQ:IRTC) Share Price Indicate?

Is iRhythm Technologies (NASDAQ:IRTC) Using Debt Sensibly?

Feb 25
Is iRhythm Technologies (NASDAQ:IRTC) Using Debt Sensibly?

Health Check: How Prudently Does iRhythm Technologies (NASDAQ:IRTC) Use Debt?

Nov 24
Health Check: How Prudently Does iRhythm Technologies (NASDAQ:IRTC) Use Debt?

iRhythm falls after reaffirming 2022 guidance

Sep 21

iRhythm: Fairly Priced At Current Multiples, No Need To Size Up

Sep 02

Is iRhythm Technologies (NASDAQ:IRTC) Using Debt In A Risky Way?

Aug 18
Is iRhythm Technologies (NASDAQ:IRTC) Using Debt In A Risky Way?

iRhythm Technologies Q2 results beat estimates, co raises FY 2022 revenue guidance

Aug 04

iRhythm Technologies provides FY22 prelims, commercial chief resigns

Jul 19

iRhythm: Reimbursement Overhang Squashed, Bull Thesis Back Intact

Jun 08

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Quentin Blackford rispetto agli utili di iRhythm Technologies?
DataCompenso totaleStipendioGuadagni aziendali
Jun 30 2024n/an/a

-US$132m

Mar 31 2024n/an/a

-US$130m

Dec 31 2023US$17mUS$677k

-US$123m

Sep 30 2023n/an/a

-US$105m

Jun 30 2023n/an/a

-US$99m

Mar 31 2023n/an/a

-US$105m

Dec 31 2022US$8mUS$650k

-US$116m

Sep 30 2022n/an/a

-US$128m

Jun 30 2022n/an/a

-US$131m

Mar 31 2022n/an/a

-US$124m

Dec 31 2021US$10mUS$163k

-US$101m

Compensazione vs Mercato: La retribuzione totale di Quentin ($USD 16.60M ) è superiore alla media delle aziende di dimensioni simili nel mercato US ($USD 5.62M ).

Compensazione vs guadagni: La retribuzione di Quentin è aumentata nonostante l'azienda non sia redditizia.


AMMINISTRATORE DELEGATO

Quentin Blackford (45 yo)

2.8yrs

Mandato

US$16,595,149

Compensazione

Mr. Quentin S. Blackford serves as an Independent Director of Paragon 28, Inc. since August 1, 2022. He serves as President and Chief Executive Officer since October 04, 2021 and serves as Director at iRhy...


Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Quentin Blackford
President2.8yrsUS$16.60m0.23%
$ 5.0m
Brice Bobzien
Chief Financial Officer2yrsUS$5.28m0.012%
$ 265.8k
Minang Turakhia
Chief Medical & Scientific Officer and Executive VP of Product Innovation2.3yrsUS$5.32m0.016%
$ 338.4k
Patrick Murphy
Chief Business & Legal Officer2.7yrsUS$5.33m0.031%
$ 666.8k
Chad Patterson
Chief Commercial Officer2.1yrsUS$5.77m0.025%
$ 548.9k
Mervin Smith
Executive Vice President of Business Operations1.1yrsNessun dato0.0023%
$ 51.0k
Marc Rosenbaum
Senior VP of Finance & Chief Accounting Officerless than a yearNessun dato0.0029%
$ 63.5k
Daniel Wilson
Executive VP of Corporate Development & Investor Relations5.2yrsUS$3.54m0.098%
$ 2.1m
Sumi Shrishrimal
Executive VP & Chief Risk Officer2.3yrsNessun dato0.075%
$ 1.6m
Stephanie Zhadkevich
Director of Investor Relationsno dataNessun datoNessun dato

2.3yrs

Durata media

45yo

Età media

Gestione esperta: Il team dirigenziale di IRTC è considerato esperto (durata media dell'incarico 2.3 anni).


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Quentin Blackford
President2.6yrsUS$16.60m0.23%
$ 5.0m
Ralph Snyderman
Independent Director7.1yrsUS$233.12k0.032%
$ 704.3k
Michael Mirro
Medical Director & Member of Scientific Advisory Boardno dataNessun datoNessun dato
Bruce Bodaken
Independent Director7.1yrsUS$240.25k0.030%
$ 659.0k
Abhijit Talwalkar
Independent Chairman8.3yrsUS$286.74k0.033%
$ 728.5k
R. Mead
Medical Director & Member of Scientific Advisory Boardno dataNessun datoNessun dato
James Quinn
Member of Scientific Advisory Boardno dataNessun datoNessun dato
Cathleen Noel Merz
Independent Director6.3yrsUS$230.62k0.018%
$ 403.2k
Mark Rubash
Independent Director8.4yrsUS$248.12k0.034%
$ 739.2k
Mehdi Razavi
Medical Director & Member of Scientific Advisory Boardno dataNessun datoNessun dato
Karen Ling
Independent Director2.8yrsUS$239.97k0.020%
$ 444.6k
Jay Alexander
Medical Director & Member of Scientific Advisory Boardno dataNessun datoNessun dato

7.1yrs

Durata media

67yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di IRTC sono considerati esperti (durata media dell'incarico 7.1 anni).